| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Sortera Technologies | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161.35M | Series C-3 | 4/20/2026 | $10M | $357.22M | $15.02 | Undisclosed Investors | ||||
 | Sprig | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $87.89M | Series B-1 | 8/30/2023 | $30M | $330.78M | $9.67 | Andreessen Horowitz, Accel | ||||
 | Two Chairs | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $92.39M | Series C | 4/16/2024 | $40M | $250.37M | $8.00 | Amplo, Fifth Down Capital | ||||
 | Wander | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $112.1M | Series B | 7/1/2026 | $64.1M | $274.1M | $3.96 | QED Investors, Fifth Wall, Redpoint, Uncork Capital, Starwood Capital Group, Breyer Capital, Authentic Ventures, Activant Capital, Hakluyt Capital, SOMA Capital, Alumni Ventures, Forecast Labs | ||||
 | WildType | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $9M | Series Seed Prime-1 | 3/25/2026 | $9M | $13.92M | $0.53 | Undisclosed Investors | ||||
 | Within | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $93.64M | Series X | 9/23/2026 | $3.02M | $316.77M | $23.22 | Accenture Ventures | ||||
 | Actively AI | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $68.24M | Series B-2 | 4/28/2026 | $12M | $247.96M | $10.75 | TCV, First Harmonic, Bain Capital, First Round Capital, Alkeon | ||||
 | Affinia Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $219.17M | Series C | 10/7/2025 | $40M | $156.61M | $1.62 | New Enterprise Associates, Eli Lilly, Alexandria Venture Investments, Atlas Venture, Avidity Partners, F-Prime Capital, GV, Mass General Brigham Ventures, Perceptive Advisors | ||||
 | Akido | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $106.75M | Series B | 5/15/2025 | $60M | $373.15M | $13.45 | Oak HC/FT, Greco, SNR, Y Combinator, Future Communities Capital, Jeff Dean, Comprehensive Blood & Cancer Center | ||||
 | Ashby | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.6M | Series D | 7/22/2025 | $50M | $492.46M | $16.21 | Alkeon, Lachy Groom, F-Prime, Elad Gil, Gaingels | ||||
 | Bathhouse | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $34.45M | Series A-1 | 3/26/2025 | $29.06M | $353.51M | $32.40 | Undisclosed Investors | ||||
 | Branch | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $129.66M | Series C | 3/9/2022 | $75.04M | $366.69M | $3.20 | Addition, General Atlantic, Drive Capital, Crosscut Ventures, Indeed | ||||
 | Cameo | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $191.36M | Series 1 | 3/13/2024 | $25.09M | $80.05M | $11.35 | Undisclosed Investors | ||||
 | Cequence Security | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $102.19M | Series C | 12/15/2021 | $66.63M | $313.72M | $2.01 | Menlo Ventures, ICON Ventures, Telstra Ventures, HarbourVest Partners, Shasta Ventures, Dell Technologies Capital, T-Mobile Ventures | ||||
 | Chia | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $80.34M | Series D | 5/24/2021 | $61M | $458.07M | $21.21 | Andreessen Horowitz, Richmond Global Ventures, True Ventures, Slow Ventures, Cygni Capital, Breyer Capital, Naval Ravikant, Collab+Currency, DHVC | ||||
 | Common | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $138.02M | Series D-2 | 2/7/2022 | $22.72M | $292.32M | $0.70 | Undisclosed Investors | ||||
 | CREXi | Real Estate Real Estate Software | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $444.04K | -- | 2 | Not available | -- | -- | $112.85M | Series B | 3/29/2022 | $40M | $491.16M | $8.56 | Brightstone Venture Capital, FJ Labs | ||||
 | Cypress | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $54.93M | Series B | 12/16/2020 | $40M | $247.26M | $11.13 | OpenView Venture Partners, Bessemer Venture Partners, Las Olas Venture Capital, Battery Ventures, Sapphire Ventures, Stripes, Gray Ventures | ||||
 | Dedrone | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $117.78M | Series C-1 | 7/13/2022 | $30M | $367.6M | $6.17 | Axon, Aqton Partners, Menlo Ventures, Felicis Ventures, Target Partners | ||||
 | Drip Capital | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $108.05M | Series C | 9/5/2024 | $63M | $346.69M | $12.79 | Transpose Platform, Accel, Sequoia, Wing Venture Capital, IRONGREY, GC1 Ventures, GMO Payment Gateway, SMBC Group, 2B Global, CSC UpShot Ventures, Endeavor8, Four Cities Capital, Peak XV Partners, Quiet Capital, Tau Ventures | ||||
 | Engrail Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $215.08M | Series B-4 | 4/7/2025 | $10M | $275.98M | $1.06 | Undisclosed Investors | ||||
 | EVERY | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $286.94M | Series D-2 | 11/4/2025 | $33.67M | $331.96M | $0.67 | McWin, Main Sequence Ventures, Bloom8, TO Ventures, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, SOSV | ||||
 | Finite State | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $91.04M | Series C-1 | 7/24/2026 | $12.5M | $121.82M | $1.08 | Undisclosed Investors | ||||
 | Hipcamp | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $99.65M | Series C | 1/7/2021 | $57.7M | $374.54M | $8.01 | Index Ventures, Bond Capital | ||||